1. Inhibition of mouse breast adenocarcinoma growth by ablation with intratumoral alpha-irradiation combined with inhibitors of immunosuppression and CpG

   • Hila Confino
   • Michael Schmidt
   • Yona Keisari

   Original Article 06 August 2016 Pages: 1149 - 1158

   

2. Inhibition of HIF-1α enhances anti-tumor effects of dendritic cell-based vaccination in a mouse model of breast cancer

   • Nasim Kheshtchin
   • Samaneh Arab
   • Jamshid Hadjati

   Original Article 06 August 2016 Pages: 1159 - 1167

   

3. The HB22.7–vcMMAE antibody–drug conjugate has efficacy against non-Hodgkin lymphoma mouse xenografts with minimal systemic toxicity

   • Mastewal Abuhay
   • Jason Kato
   • Joseph M. Tuscano

   Original Article 09 August 2016 Pages: 1169 - 1175

   

4. Identification of a naturally processed HLA-A*02:01-restricted CTL epitope from the human tumor-associated antigen Nectin-4

   • Marc Lopez
   • Abderrezak Ghidouche
   • Daniel Olive

   Original Article 11 August 2016 Pages: 1177 - 1188

   

5. Intratumoral interferon-gamma increases chemokine production but fails to increase T cell infiltration of human melanoma metastases

   • Ileana S. Mauldin
   • Nolan A. Wages
   • Craig L. Slingluff Jr.

   Original Article 13 August 2016 Pages: 1189 - 1199

   

6. Topical treatment of melanoma metastases with imiquimod, plus administration of a cancer vaccine, promotes immune signatures in the metastases

   • Ileana S. Mauldin
   • Nolan A. Wages
   • Craig L. Slingluff Jr.

   Original Article 13 August 2016 Pages: 1201 - 1212

   

7. Prognostic significance of HLA class I and II expression in patients with diffuse large B cell lymphoma treated with standard chemoimmunotherapy

   • Kohei Tada
   • Akiko Miyagi Maeshima
   • Yukio Kobayashi

   Original Article 13 August 2016 Pages: 1213 - 1222

   

8. Immunological evaluation of personalized peptide vaccination for patients with histologically unfavorable carcinoma of unknown primary site

   • Shinjiro Sakamoto
   • Shigeru Yutani
   • Masanori Noguchi

   Original Article 22 August 2016 Pages: 1223 - 1231

   

9. A panel of autoantibodies against multiple tumor-associated antigens in the immunodiagnosis of esophageal squamous cell cancer

   • Hong-Fei Zhang
   • Jie-Jie Qin
   • Jian-Ying Zhang

   Original Article 23 August 2016 Pages: 1233 - 1242

   

10. 4-1BB agonism: adding the accelerator to cancer immunotherapy

    • Cariad Chester
    • Siddhant Ambulkar
    • Holbrook E. Kohrt

    Focussed Research Review Open access 31 March 2016 Pages: 1243 - 1248

11. Opportunities for immunotherapy in microsatellite instable colorectal cancer

    • Harm Westdorp
    • Felix L. Fennemann
    • I. Jolanda M. de Vries

    Focussed Research Review Open access 08 April 2016 Pages: 1249 - 1259

    

12. Modulation of innate immunity in the tumor microenvironment

    • Elena Gonzalez-Gugel
    • Mansi Saxena
    • Nina Bhardwaj

    Focussed Research Review 25 June 2016 Pages: 1261 - 1268

    

13. Concepts in glioma immunotherapy

    • Michael Platten
    • Lukas Bunse
    • Theresa Bunse

    Focussed Research Review 26 July 2016 Pages: 1269 - 1275

    

14. The right patient for the right therapy: 13th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 11–13, 2015

    • Matthias Miller
    • Veronika Jahndel
    • Björn-Philipp Kloke

    Meeting Report 03 June 2016 Pages: 1277 - 1287